Hyde v. Humana Ins. Co., Inc.

598 So. 2d 876, 1992 Ala. LEXIS 470, 1992 WL 86311
CourtSupreme Court of Alabama
DecidedMay 1, 1992
Docket1902011
StatusPublished
Cited by2 cases

This text of 598 So. 2d 876 (Hyde v. Humana Ins. Co., Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hyde v. Humana Ins. Co., Inc., 598 So. 2d 876, 1992 Ala. LEXIS 470, 1992 WL 86311 (Ala. 1992).

Opinion

STEAGALL, Justice.

John Hyde appeals from a summary judgment for the defendants, Humana Insurance Company, Inc. (“HIC”), and Huma-na, Inc., in his lawsuit alleging breach of contract, bad faith failure to pay an insurance claim, and the tort of outrage.

Hyde, a licensed agent with HIC who sold renewals of Medicare policies, was insured under a group medical insurance policy offered by HIC. That contract became effective on May 1, 1988, and contained a “Major Transplant Benefit Rider,” which provided, in pertinent part:

“MAJOR TRANSPLANT means pretran-splant, transplant and post-discharge services, supplies, care and treatment received for or in connection with the medically necessary transplantation of the following human organs or tissue: heart, liver, kidney and bone marrow. “For a major transplant procedure to be considered approved to this Major Transplant Benefit, prior approval from our Medical Affairs Department in advance of the procedure is required. Such approval will be based on written criteria and procedures established by our Medical Affairs Department. If approval is given, the insured person will automatically be placed in the Medical Case Management Program, as described in this Group Policy. If approval is not given, benefits will not be provided for the procedure.”

(Emphasis added.) One of three exclusions to that rider reads: “No benefit is payable for or in connection with a major transplant if: ... 2. Our Medical Affairs Department does not approve coverage for the procedure, based on established criteria for medical necessity or based on a determination that the procedure is experimental for the condition involved.” (Emphasis added.)

On September 21, 1988, Hyde was hospitalized with severe hepatic cirrhosis; he was hospitalized two more times, in October and November 1988, with “near end stage cirrhosis.” By the fall of 1989, Hyde’s treating physician, Dr. Bart Mitchell, recommended that Hyde undergo a liver transplant. Hyde contacted HIC on December 29, 1989, and, in accordance with his insurance contract, requested pre-ap-proval for the transplant. In a letter dated January 8, 1990, Dr. Ronald S. Lankford, vice president of medical affairs with Hu-mana, Inc., wrote Dr. Mitchell and requested medical information regarding Hyde.1

[878]*878Hereinafter, “Humana” will collectively refer to HIC and Humana, Inc.

Hyde was hospitalized at Humana Hospital Shoals on January 16, 1990, for liver failure and an incarcerated inguinal hernia and was transferred the following day to the University of Alabama Hospital in Birmingham, where Dr. Steven Poplawski, director of the liver transplant unit, began the pretransplant evaluation process. On January 17, 1990, Dr. Lankford wrote Dr. Mitchell a letter containing, in pertinent part, the following:

“The request for coverage of a liver transplant for John Hyde has been reviewed by our Medical Affairs Department. Based on the information provided, the coverage of this procedure has been denied because Humana covers liver transplants only for biliary atresia and certain congenital metabolic disorders. “If the procedure is performed regardless of this denial, benefits will not be granted for any complications arising from such procedure.”

About two weeks later, Hyde wrote to the Humana Medical Affairs Department and asked that it reconsider the denial of coverage in his case. Dr. Lankford wrote Hyde the following letter on February 6, 1990:

“Thank you for your letter regarding the potential need for a liver transplant. As we stated in a letter to your physician on January 17, Humana provides liver transplant benefits only for biliary atresia and certain congenital metabolic disorders. “Humana’s Major Transplant Rider, to which you referred states:
“ ‘For a major transplant procedure to be considered approved to the Major Transplant Benefit, prior approval from our Medical Affairs Department in advance of the procedure is required. Such approval will be based on written criteria and procedures established by our Medical Affairs Department.’
“That written medical criteria [sic] has been applied to your case. We are sorry that this decision cannot be more favorable.”

(Emphasis added.)

Hyde initially decided to forgo the transplant upon learning that it would cost $150,000; however, on February 22, 1990, Hyde’s wife came home and found him unconscious. He was taken to Humana Hospital Shoals, where he remained until March 2, 1990. Upon Hyde’s returning [879]*879home, he decided to undergo the operation, which he had on March 28, 1990, at the University of Alabama Hospital in Birmingham.2 Humana “administratively” approved coverage for the transplant on April 19, 1990. In his letter notifying one of Hyde’s doctors of Humana’s reconsideration, Dr. Lankford stated, “This decision does not alter our prior determination that Mr. Hyde does not contractually meet our liver transplant criteria.”

BREACH OF CONTRACT

The “written medical criteria” Dr. Lankford referred to are those stated in the “HUMANA HEALTH CARE DIVISION TRANSPLANT COVERAGE CRITERIA,” a two-page document specifically addressing six different transplant procedures. The third provision is entitled “LIVER TRANSPLANT,” and it reads:

“Benefits will be provided for only those cases arising from biliary atresia in any age and certain congenital metabolic disorders in members 17 years of age or less.
“If the candidate has one of these diagnoses and meets Humana’s criteria (Attachment B), the candidate will be approved for transplant benefits.”

Attachment B consists of 10 questions dealing with, for instance, whether the patient is “encephalopathic” or “septic.”

It is apparent from Dr. Lankford’s letters to Hyde and Dr. Mitchell that the above “medical criteria,” as they are referred to in the parties’ briefs, were the basis for Humana’s denial of coverage, not whether Hyde’s operation was medically necessary or experimental. Our query, therefore, becomes whether the incorporation by reference in Hyde’s policy of the medical criteria was valid.

Ala.Code 1975, § 27-14-13, entitled “Charter, bylaws, etc., of insurer as part of contract,” reads:

“No policy shall contain any provision purporting to make any portion of the charter, bylaws or other constituent document of the insurer, other than the subscriber s agreement or power of attorney of a reciprocal insurer, a part of the contract unless such portion is set forth in full in the policy. Any policy provision in violation of this section shall be invalid.”

(Emphasis added.) Statutes similar to § 27-14-13 have been interpreted as follows:

“A statute providing that an application, by-laws, and rules or parts thereof, unless attached to or printed on the policy, shall not be considered a part of the policy, is mandatory. While the parties may, subject to statutory restrictions, determine what terms shall be inserted in a life policy, a statute requiring endorsement or attachment defines the form they must use.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

First Financial Ins. Co. v. Tillery
626 So. 2d 1252 (Supreme Court of Alabama, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
598 So. 2d 876, 1992 Ala. LEXIS 470, 1992 WL 86311, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hyde-v-humana-ins-co-inc-ala-1992.